[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100618754":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":20,"locations":26,"responsibleParty":38,"collaborators":11,"id":42,"slug":11,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":45,"acronym":11,"eligibilityCriteria":46,"healthyVolunteers":43,"sex":47,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":11,"studyType":53,"phases":54,"briefSummary":56,"conditions":57,"keywords":11,"overallStatus":28,"whyStopped":11,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"China-Japan Friendship Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Robotic surgical treatment group","EXPERIMENTAL",null,[13],"Device: Robot-assisted single-port bariatric surgery",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"DEVICE","Robot-assisted single-port bariatric surgery","For overweight or obese patients (BMI≥27.5kg\u002Fm2) who meet the indications for metabolic surgery, single-port robot-assisted sleeve gastrectomy or gastric bypass surgery is performed.",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":11,"email":25},"SIQi Wang","CONTACT","18810315722","menghuade@hotmail.com",[27],{"facility":5,"status":28,"city":29,"state":11,"zip":11,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":11},"RECRUITING","Beijing","China","CN",{"type":33,"coordinates":34},"Point",[35,36],116.39723,39.9075,{"lat":36,"lon":35},{"type":39,"investigatorFullName":40,"investigatorTitle":41,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Hua Meng","Director of the General Surgery Department & Obesity and Metabolic Disease Center of China-Japan Friendship Hospital","100618754",false,"NCT07335731","Study on the Safety and Efficacy of Domestic Single-Port Robot-Assisted Metabolic Bariatric Surgery.","Inclusion Criteria:\n\n* ①Overweight or obese patients who meet the criteria for metabolic weight loss surgery, with a BMI ≥ 27.5 kg\u002Fm2; ② Patients who understand the purpose of the trial, voluntarily participate in the trial, and sign an informed consent form.\n\nExclusion Criteria:\n\n* ① Patients who cannot tolerate general anesthesia, such as those with severe heart, lung, or liver dysfunction; ② Patients with severe coagulation disorders; ③ Pregnant patients; ④ Patients with concurrent tumors; ⑤ Patients with extensive and severe abdominal adhesions that prevent the establishment of pneumoperitoneum; ⑥ A BMI \\> 50 kg\u002Fm² is a relative contraindication; ⑦ Patients deemed unsuitable for participation in this trial by any other investigator.","ALL","18 Years","65 Years",{"count":51,"type":52},50,"ESTIMATED","INTERVENTIONAL",[55],"NA","This study aims to obtain short-term clinical results on the safety and efficacy of single-port robot-assisted metabolic weight loss surgery, and to provide further evidence for the clinical promotion of single-port robot systems.",[58,59],"Obesity","Robot Surgery","2026-01-12",{"date":62,"type":63},"2026-01-13","ACTUAL",{"date":65,"type":63},"2025-07-10",{"date":67,"type":52},"2027-07-30",{"name":5,"class":6},1]